Robert I. Liem, MD

Clinical and Community Trials

Research Interests

  • Sickle Cell Disease
  • Exercise Physiology
  • Health Disparities

Biography

  • Interim Division Head, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Section Head, Hematology, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Director, Comprehensive Sickle Cell Program, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Associate Chair for Ambulatory Services, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago
  • A. Watson and Sarah Armour Professorship in Childhood Cancer and Blood Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago
  • Professor of Pediatrics, Northwestern University Feinberg School of Medicine

See Lurie Children's Provider Profile

Education and Background

  • Fellowship in Pediatric Hematology/Oncology, Johns Hopkins Hospital and the National Cancer Institute 2001-2004
  • Chief Resident, Children's Memorial Hospital 2000-2001
  • Resident, Pediatrics, Children's Memorial Hospital 1997-2000
  • Northwestern University 1997

Clinical Studies

Recruiting

Pediatric Open-Label Extension of Voxelotor

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease

A Safety and Efficacy Study Evaluating CTX001 in Subjects With Transfusion-Dependent β-Thalassemia

Recruiting

EDIT-301 for Autologous HSCT in Subjects With Severe Sickle Cell Disease

Recruiting

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Recruiting

Sickle Cell Pro-Inflammatory Response to Interval Training Study

Recruiting

Exercise in Child Health

Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

Recruiting

Longterm Follow-up of Subjects With Transfusion-Dependent β-Thalassemia Treated With Ex Vivo Gene Therapy

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

Publications

Apr. 21, 2022

Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years

Jan. 01, 2022

Heart rate variability associated with acute exercise challenge in children with sickle cell anaemia.

Jan. 01, 2022

Cerebral and skeletal muscle tissue oxygenation during exercise challenge in children and young adults with sickle cell anaemia.

See all publications

Similar Researchers

Clinical and Community Trials

Andrew Prigge, MD

Research Interests

Critical Care, Viral Respiratory Infections, Lung Injury and Repair, Immune Regulation

Recent Publication

Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.

Feb. 01, 2022
Clinical and Community Trials

Brian A. Madden, MD

Research Interests

Interventricular Mechanics, Right Ventricular Failure, Role of Immunologic Phenotype on Post-heart Transplant Outcomes, Post-heart Transplant Kidney Injury and Failure

Clinical and Community Trials

Jeremy N. Wong, MD

Laura E. Vernon, MD

Reega D. Purohit, MD

Alexander J. Kula, MD